Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(+)-α-methylphenylethylamine
(αS)-α-methylbenzeneethanamine
Dexanfetamina
Dexamfetamine
Dextroamphetamine sulfate
(+)-α-methylphenethylamine
Dextroamphetamine
(S)-α-methylbenzeneethanamine
(S)-1-phenyl-2-aminopropane
(+)-amphetamine
d-amphetamine
Dexamfetamina
(+)-(S)-amphetamine
(S)-amphetamine
(S)-(+)-amphetamine
Dexamfetaminum
Dextroamphetamine adipate
(S)-1-phenyl-2-propylamine
Dextroamphetamine saccharate
(S)-(+)-β-phenylisopropylamine
Desamfetamina
Dexamphetamine
Brand Names
Xelstrym
Dexedrine Spansule Src 10mg
Mixed Salts of a Single-Entity Amphetamine Product
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
